Bio-Techne Corp/ US09073M1045 /
| 2024-06-07 9:59:57 PM | Chg. -1.21 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 77.64USD | -1.53% | 27,041 Turnover: 2.1 mill. |
-Bid Size: - | -Ask Size: - | 3.06 bill.USD | 1.64% | 11.24 |
Assets
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 135.1000 | 145.3000 | 154 | 176.8000 | 207.9000 | ||||||
| Intangible Assets | 452 | 446.3000 | 579.4000 | 516.5000 | 616 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | - | - | - | ||||||
| Inventories | 60.2000 | 85.6000 | 91.1000 | 103.2000 | 116.7000 | ||||||
| Accounts Receivable | 116.8000 | 120.3000 | 137.5000 | 122.5000 | 145.4000 | ||||||
| Cash and Cash Equivalents | 91.6000 | 122 | 100.9000 | 146.6000 | 199.1000 | ||||||
| Current Assets | 348 | 398.4000 | 412.6000 | 520.9000 | 510.6000 | ||||||
| Total Assets | 1,558.2000 | 1,593.2000 | 1,884.4000 | 2,027.6000 | 2,263 | ||||||
Liabilities
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 16.9000 | 18.5000 | 16.2000 | 23.1000 | 29.4000 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 120.6000 | 86.3000 | 89.8000 | 101.1000 | 93.1000 | ||||||
| Liabilities | 608.6000 | 514.1000 | 718.8000 | 646.4000 | 691.8000 | ||||||
| Share Capital | - | - | - | - | - | ||||||
| Total Equity | 949.6000 | 1,079.1000 | 1,165.6000 | 1,381.2000 | 1,571.2000 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 8.3000 | ||||||
| Total liabilities equity | 1,558.2000 | 1,593.2000 | 1,884.4000 | 2,027.6000 | 2,263 | ||||||
Income Statement
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 563 | 643 | 714 | 738.7000 | 931 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 120.6000 | 136.2000 | 146.7000 | 157.4000 | 237.3000 | ||||||
| Interest Income | -7.1000 | -9.8000 | -21.1000 | -18.6000 | -13.5000 | ||||||
| Income Before Taxes | 112 | 126 | 112 | 276.5000 | 148.2000 | ||||||
| Income Taxes | 35.9000 | -.2000 | 15.9000 | 47.2000 | 8.6000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | .8000 | ||||||
| Net Income | 76.1000 | 126.2000 | 96.1000 | 229.3000 | 140.4000 | ||||||
Per Share
Cash Flow
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 143.4000 | 170.4000 | 181.6000 | 205.2000 | 352.2000 | ||||||
| Cash Flow from Investing Activities | -306 | -38.7000 | -336.8000 | 27.1000 | -243.5000 | ||||||
| Cash Flow from Financing | 189.4000 | -99.2000 | 134.4000 | -183.8000 | -62.6000 | ||||||
| Decrease / Increase in Cash | 27.4000 | 30.4000 | -21.1000 | 45.7000 | 52.5000 | ||||||
| Employees | 1,800 | 2,000 | 2,250 | 2,300 | 2,000 | ||||||
